GSK

GSK

Yahoo Finance • 4 days ago

FTSE 100 today: Stocks fall as crude slide drags oil majors lower

Investing.com -- British stocks fell on Monday as a slide in crude on hopes of progress in indirect U.S.-Iran talks dragged down oil majors, weighing on the index. Still guessing which stocks will beat the market? Our AI portfolio updates... Full story

Yahoo Finance • 5 days ago

Top global stories this week: Shell, HSBC, SK Hynix among notable names

US stock indexes ended the week lower following disappointing earnings from major US tech companies. Persistent concerns about the AI trade have also weighed. Out of the 177 S&P 500 companies that reported earnings this week [https://seek... Full story

Yahoo Finance • 8 days ago

Parse Biosciences and Nomic Announce 100 Million Cell, Multimodal AI-ready Dataset for Immune Biology

Licensable perturbation dataset to include transcriptomes and proteomic secretomes for understanding the human immune response SEATTLE & MONTREAL, October 29, 2026--(BUSINESS WIRE)--Parse Biosciences, the leading provider of scalable and... Full story

Yahoo Finance • 8 days ago

Chiesi Group appoints Paolo Paoletti to its Board of Directors

HIGHLIGHTS: Paolo Paoletti, M.D., joins Chiesi's Board of Directors as its fourth independent member, effective as of today. An internationally recognized pharmaceutical leader, he brings more than 30 years of experience spanning R&D, bio... Full story

Yahoo Finance • 8 days ago

GSK (LSE:GSK) Shares Dropped, So What Is Behind The Latest Attention?

GSK (LSE:GSK) has released third quarter figures that present a mixed picture. Sales reached £8,887 million, while net income declined to £1,543 million compared with £2,013 million a year earlier. The latest figures landed alongside a sh... Full story

Yahoo Finance • 8 days ago

Genmab Stock Surges to Record High as Cancer Drug Slashes Risk of Death by 50%

Genmab scores a ‘hat trick’ with positive data for its experimental cancer drug, petosemtamab, Jefferies says. Continue Reading... Full story

Yahoo Finance • 9 days ago

FTSE 100 today: Stocks slip ahead of budget; GSK, Unilever results weigh

Investing.com -- British stocks fell on Wednesday as investors awaited the budget and weighed results from heavyweights GSK and Unilever. Still guessing which stocks will beat the market? Our AI portfolio updates monthly and is outperform... Full story

Yahoo Finance • 9 days ago

GSK beats Q3 profit estimates on specialty medicines strength

Investing.com -- GSK PLC reported third-quarter results that exceeded analyst expectations, with adjusted earnings per share of 54.6 pence compared to the consensus estimate of 50.4 pence. Still guessing which stocks will beat the market?... Full story

Yahoo Finance • 10 days ago

What Could GSK (LSE:GSK) Oncology Progress Mean For Investors?

GSK (LSE:GSK) presented new late stage oncology data at the ESMO Congress on Jemperli, Mo-Rez and Ris-Rez in October 2026. Jemperli received FDA accelerated approval for MSI-H/dMMR locally advanced rectal cancer, enabling some patients to... Full story

Yahoo Finance • 12 days ago

Earnings Week Ahead: MSFT, GOOGL, AMZN, XOM, BA, VZ, and more

[Rolled newspaper with the headline Quarterly Results] Zerbor Another heavyweight earnings week is ahead, with results from Big Tech, energy giants, chipmakers, financial services, healthcare, and industrial leaders set to offer a broad r... Full story

Yahoo Finance • 14 days ago

How First In Class Hepatitis B Approval At GSK (LSE:GSK) Has Changed Its Investment Story

GSK received FDA approval for Hibsago, an antisense oligonucleotide injection used with existing antiviral therapy to treat certain adults with chronic hepatitis B without cirrhosis, supported by phase III data showing functional cure in a... Full story

Yahoo Finance • 15 days ago

UK Stock Market Today: FTSE 100 Futures Edge Lower On Sticky Inflation Concerns

The Morning Bull - UK Market Morning Update Thursday, 22 Oct 2026 UK markets are set for a cautious, inflation-focused open after hotter price data reset rate expectations. The mood leans defensive as investors digest stronger domestic co... Full story

Yahoo Finance • 16 days ago

Five years of U.S. real-world evidence reinforce the durable effectiveness and long-term persistence of ViiV Healthcare’s Cabenuva

77% of participants remained in care and on long-acting HIV treatment, Cabenuva, with a median treatment duration of 18 months Among individuals switching to Cabenuva, 94% had a last viral load <50 copies/mL and 81% maintained continuous v... Full story

Yahoo Finance • 16 days ago

CSL appoints Deborah Waterhouse as CEO &amp; Managing Director

MELBOURNE, Australia, Oct. 21, 2026 /PRNewswire/ -- The Board of Directors of CSL Limited (ASX:CSL; USOTC:CSLLY) today announces that it has appointed Deborah Waterhouse as Chief Executive Officer and Managing Director of CSL from 1 Februa... Full story

Yahoo Finance • 17 days ago

Jemperli (dostarlimab-gxly) approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer

Approval based on AZUR-1 data showing clinically significant proportion of participants with no detectable signs of cancer one year or more after treatment No disease recurrences reported among responders after median follow up of more tha... Full story

Yahoo Finance • 26 days ago

Hospital group files lawsuit to stop 340B rebate pilot again

[An overturned pill bottle spills cash and medicinal capsules] Enrique Yocoyani Aguilar Licona/iStock via Getty Images The American Hospital Association has once again filed a lawsuit to halt a new pilot that tests a revised rebate model... Full story

Yahoo Finance • 29 days ago

GSK (LSE:GSK) Deepens Its Drug Pipeline Through Two Research Partnerships

GSK (LSE:GSK) has entered a collaboration with Wave Life Sciences to advance a GalNAc-siRNA hepatology candidate into its development pipeline. The partnership with Wave Life Sciences focuses on RNA-based therapies targeting liver diseases... Full story

Yahoo Finance • last month

AbbVie, Amgen, Pfizer, GSK among participants in new 340B rebate pilot

The Trump administration has selected 10 companies, including AbbVie (ABBV [https://seekingalpha.com/symbol/ABBV]), Amgen (AMGN [https://seekingalpha.com/symbol/AMGN]), Pfizer (PFE [https://seekingalpha.com/symbol/PFE]), and GSK (GSK [http... Full story

Yahoo Finance • last month

Abbott Stock And Other Healthcare Dividend Names Built For Supply Chain Shocks

Markets are back to obsessing over central bank signals, supply routes and growth downgrades, and that mix is shaking up how investors look at reliable income. When credit feels tighter and headlines keep flagging disruption risks, steady... Full story

Yahoo Finance • last month

Pharmaceutical industry lobbying group names new CEO, Eric Cantor

[Cantor And John Thune Hold Press Conference On Economy] Alex Wong/Getty Images News * The Pharmaceutical Research and Manufacturers of America (PhRMA) has selected former Republican House Majority Leader Eric Cantor as its next CEO and... Full story